Shahrokh Shabahang - May 25, 2021 Form 4 Insider Report for Aditx Therapeutics, Inc. (ADTX)

Role
CHIEF INNOVATION OFFICER, Director
Signature
/s/ Shahrokh Shabahang
Stock symbol
ADTX
Transactions as of
May 25, 2021
Transactions value $
$1,498
Form type
4
Date filed
5/28/2021, 06:49 PM
Next filing
Jun 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADTX Common Stock Purchase $670 +279 +0.03% $2.40* 1.02M May 25, 2021 By son F1
transaction ADTX Common Stock Purchase $328 +138 +0.01% $2.38* 1.02M May 25, 2021 By son F1
transaction ADTX Common Stock Purchase $500 +185 +0.02% $2.70* 1.02M May 27, 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F2 Fractional amounts have been rounded to the nearest whole number.